Octagon Capital Advisors LP - 30 Sep 2025 SCHEDULE 13G/A Report for Taysha Gene Therapies, Inc. Common Stock, $0.00001 par value (TSHA)

Filing Manager
Octagon Capital Advisors LP
Reporting Manager
Octagon Capital Advisors LP
Security
Taysha Gene Therapies, Inc. Common Stock, $0.00001 par value
Symbol
TSHA
Shares outstanding
274,772,727 shares
Disclosed Ownership
9,067,500 shares
Ownership
3.3%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 16:46:07 UTC
Date of event
30 Sep 2025
Previous filing
05 Feb 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Octagon Capital Advisors LP 3.3% 9,067,500 0 9,067,500 /s/ Ting Jia Managing Member
Octagon Investments Master Fund 3.3% 9,067,500 0 9,067,500 /s/ Ting Jia Managing Member, Octagon Investments GP, LLC, its general partner
Ting Jia 3.3% 9,067,500 0 9,067,500 /s/ Ting Jia Ting Jia